Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
June 26, 2024 08:30 ET
|
Cibus US LLC
Additional patents issued for 10 plant trait and editing families in the past two quarters. Strengthens Cibus’ intellectual property portfolio in its Pod Shatter Reduction (PSR), Herbicide Tolerances...
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
June 17, 2024 07:00 ET
|
Cibus US LLC
Nutrient Use Efficiency Traits are an Important Large Category of Traits that can Make Fertilizer Use More Efficient on a Global Basis The First Case of Cibus Using its Trait Machine Process for...
Cibus Announces $13.0 Million Registered Direct Offering
June 12, 2024 08:00 ET
|
Cibus US LLC
SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to...
Cibus to Participate in Upcoming June Investor Events
June 05, 2024 07:00 ET
|
Cibus US LLC
SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today...
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
May 30, 2024 07:00 ET
|
Cibus US LLC
Cibus has successfully made the edits in Canola associated with the Company’s 3rd mode of action for its White Mold (Sclerotinia) trait These next generation edits are now confirmed in plants and...
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
May 15, 2024 07:00 ET
|
Cibus US LLC
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant...
Cibus to Participate in the BMO Global Farm to Market Conference
May 13, 2024 07:00 ET
|
Cibus US LLC
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or...
Cibus Reports First Quarter Financial Results and Provides Business Update
May 09, 2024 16:05 ET
|
Cibus US LLC
Important EU Parliament vote on gene editing continues global momentum for the approval of new genomic techniques (NGTs) as similar to conventional breeding Completed single cell regeneration...
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
April 25, 2024 07:00 ET
|
Cibus US LLC
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or...
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
March 21, 2024 16:05 ET
|
Cibus US LLC
Completed successful transfers of gene edited elite germplasm back to customers for commercialization for each of its three developed productivity traits: Pod Shatter Reduction (PSR) in Canola and...